NM_001250.6(CD40):c.606C>T (p.Phe202=) AND Hyper-IgM syndrome type 3
- Germline classification:
- Benign (2 submissions)
- Last evaluated:
- Nov 29, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV001000341.13
Allele description [Variation Report for NM_001250.6(CD40):c.606C>T (p.Phe202=)]
NM_001250.6(CD40):c.606C>T (p.Phe202=)
Condition(s)
Assertion and evidence details
Last Updated: Sep 29, 2024